Monographie - Oxaliplatin

Zadnji put ažurirano :
19/11/2024

Oxaliplatin

Kemijska struktura

Nekomercijalni

Zaštićeni nazivi su indikativni i sastav ekscipijensa može biti različit ovisno o državi i laboratorijima

Axiplatin	Njemačka
Bendaplatin	Njemačka
Bioezulen	Brazil
Celdach	Peru
Crisapla	Čile, Ekvador, Venecuela
Crisatinox	Turska
Dabenzol	Argentina, Ekvador
Dacplat	Argentina
Eloxarin	Ekvador
Eloxatin	Austrija, Belgija, Brazil, Čile, Egipat, Iran, Italija, Kolumbija, Luksemburg, Malezija, Meksiko, Norveška, novi Zeland, Peru, Portugal, Rumunjska, S A D, Španjolska, Švedska, Švicarska, Tajland, Turska, Ujedinjeni Arapski Emirati, Velika Britanija, Venecuela
Eloxatine	Francuska, Maroko, Švicarska
Entia	Kolumbija, Meksiko
Euroxaliplatine	Njemačka
Glenoxal	Peru
Goxyral	Argentina, Ekvador
Kebir	Argentina, Peru
Linoxa	Turska
Lisix	Čile
Metaplatin	Argentina
Oliptino	Argentina
Onicol	Čile, Peru
Oxalibbs	Brazil
Oxaliplan	Njemačka
Riboxatin	Njemačka

Bibliografija : Oxaliplatin

	Vrsta	Publikacija
1662	Časopis	Trissel LA, Saenz CA, Ingram DS, Ogundele AB. Compatibility screening of oxaliplatin during simulated Y-site administration with other drugs. J Oncol Pharm Practice 2002 ; 8: 33-37.
1950	Časopis	Trissel LA, Yanping Z. Physical and chemical stability of palonosetron HCl with cisplatin, carboplatin and oxaliplatin during simulated Y-site administration. J Oncol Pharm Practice 2004 ; 10: 191-195.
2207	Časopis	André A, Cisternino S, Roy A.L, Chiadmi F, Schlatter J, Agranat P, Fain O, Fontan J.E. Stability of oxaliplatin in infusion bags containing 5% dextrose injection. Am J Health-Syst Pharm 2007 ; 64, 18: 1950-1954.
2239	Časopis	Wang C, Zhang X, Liu HY. Determination of the stability of oxaliplatin for injection by dual wavelength spectrophotometry. Chinese J New Drugs 2005 ; 14, 2: 189-191.
2253	Časopis	Curis E, Provost K, Bouvet D, Nicolis I, Crauste-manciet S, Brossard D, B?nazeth S. Carboplatin and oxaliplatin decomposition in chloride medium, monitored by XAS. J Synchrotron Rad 2001 ; 8: 716-718.
2258	Laboratorija	Stability of oxaliplatin "Ebewe" lyophilisate after reconstitution. Ebewe Pharma 2007
2259	Laboratorija	Stability of oxaliplatin "Ebewe" lyophilisate infusion solutions. Ebewe Pharma 2007
2321	Časopis	Junker A, Roy S, Desroches M.C, Moussay C, Berhoune M, Bellanger A, Fernandez C,Farinotti R. Stability of Oxaliplatin Solution. Ann Pharmacotherapy 2009 ; 43,2: 390-391.
2791	Časopis	Mehta A.M,.Van den Hoven J.M, Rosing H,.Hillebrand M.J.X, Nuijen B,. Huitema A.D.R, Beijnen J.H,.Verwaal V.J. Stability of oxaliplatin in chloride-containing carrier solutions used in hyperthermic intraperitoneal chemotherapy. Int J Pharm 2015 ; 479 : 23-27.
2883	Časopis	Eiden C, Philibert L, Bekhtari K, Poujol S, Malosse F, Fr?d?ric Pinguet F. Physicochemical stability of oxaliplatin in 5% dextrose injection stored in polyvinyl chloride, polyethylene, and polypropylene infusion bags. Am J Health-Syst Pharm 2009 ; 66, 21: 1929-1933.
3369	Laboratorija	Levofolinate de sodium Medac - Résumé des caractéristiques du produits MEDAC France 2011
3413	Časopis	Jerremalm E, Hedeland M, Wallin I, Bondesson U, Ehrsson H. Oxaliplatin degradation in the presence of chloride: Identification and cytotoxicity of the monochloro monooxalato complex. Pharm Res 2004 ; 21, 5: 891-894.
3602	Laboratorija	Mesna (Uromitexan®)- Summary of Product Characteristics Baxter SAS 2013
3634	Laboratorija	Oxaliplatine (Oxaliplatine Accord®) - Résumé des caractéristiques du produit Accord Healthcare 2011
3670	Časopis	Sewell G, Massimini M. Studies on the stability and compatibility of cytotoxic drug infusion with the Tevadaptor system. EJOP 2014 ; 8, 3: 26-30.
3706	Časopis	Escudero-Ortiz V, Duart-Duart M.J, P?rez-Ruixo C, P?rez-Ruixo J.J, Valenzuela B. Estudio de estabilidad de oxaliplatino y doxorrubicina para su administración intraperitoneal con hipertermia. Farm Hosp 2014 ;38, 3:154-161
4004	Časopis	Krämer I, Sarakbi I, Thiesen J, Mainz. Physikalisch-chemische Stabilität von Oxaliplatin-beta-Infusionslösungskonzentrat und Infusionslösungen in 5 % Glucose in Polyolefin-Infusionsbeuteln. Krankenhauspharmazie 2017 ;38,7:334?340.

Mentions Légales